Proteomics reveals protein shifts in diabetic eye disease
Diabetic retinopathy, DR, is the leading cause of blindness and vision impairment in adults under 40 in developed countries. Many cases progress to vision-threatening stages, including proliferative diabetic retinopathy, PDR, and neovascular glaucoma, NVG. To investigate the molecular mechanisms driving this progression and identify potential biomarkers, Jae Won Oh and colleagues in South Korea used label-free quantification and tandem mass tagging to profile the clear fluid found at the front of the eye, known as aqueous humor, from patients with nonproliferative DR, NPDR, PDR and NVG. Their findings, published in Molecular & Cellular Proteomics, identified proteins that differed across DR stages.
The researchers used triple-quadrupole mass spectrometry to validate the potential biomarker expression, including APOB, TF and S100A7. These proteins showed markedly different expression levels between NPDR and PDR, as well as between PDR and NVG. Between NPDR and PDR, levels of S100A7, a protein linked to inflammation, increased, suggesting an early activation of inflammatory pathways. In contrast, structural lens proteins, more abundant in NPDR, began to decline in PDR, indicating a shift away from tissue maintenance toward stress response. As the disease advanced from PDR to NVG, proteins like APOB and TF, which are involved in fat transport and immune regulation, continued to rise in expression. APOB stood out as a key marker of the most severe stage, NVG, showing a clear increase in levels compared to earlier stages. These shifts in protein expression reflect how the disease moves from affecting eye tissue and vision early on to involving more serious inflammation and damage in the later stages.
These findings provide key insight into the molecular progression of diabetic retinopathy and highlight stage-specific protein changes that could serve as biomarkers. By uncovering potential targets for earlier diagnosis and tailored treatment, this study lays the groundwork for improved management of vision-threatening diabetic eye disease.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Cholesterol as a novel biomarker for Fragile X syndrome
Researchers in Quebec identified lower levels of a brain cholesterol metabolite, 24-hydroxycholesterol, in patients with fragile X syndrome, a finding that could provide a simple blood-based biomarker for understanding and managing the condition.
How lipid metabolism shapes sperm development
Researchers at Hokkaido University identify the enzyme behind a key lipid in sperm development. The findings reveal how seminolipids shape sperm formation and may inform future diagnostics and treatments for male infertility.
Mass spec method captures proteins in native membranes
Yale scientists developed a mass spec protocol that keeps proteins in their native environment, detects intact protein complexes and tracks drug binding, offering a clearer view of membrane biology.
Laser-assisted cryoEM method preserves protein structure
University of Wisconsin–Madison researchers devised a method that prevents protein compaction during cryoEM prep, restoring natural structure for mass spec studies. The approach could expand high-resolution imaging to more complex protein systems.
Method sharpens proteome-wide view of structural changes
Researchers developed a method that improves limited proteolysis coupled with mass spectrometry, separating true changes from abundance or splicing effects.
Discoveries made possible by DNA
The discovery of DNA’s double helix revealed how genetic information is stored, copied and expressed. Revisit that breakthrough and traces how it laid the foundation for modern molecular biology, genomics and biotechnology.